Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Nutlin-3a |
| Trade Name | |
| Synonyms | Nutlin|Nutlin-3 |
| Drug Descriptions |
Nutlin-3a is an MDM2 inhibitor that activates p53, potentially resulting in induction of apoptosis and senescence in tumor cells (PMID: 18451145, PMID: 32653500). |
| DrugClasses | MDM2 Inhibitor 23 |
| CAS Registry Number | 548472-68-0 |
| NCIT ID | C74594 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + Nutlin-3a | Carboplatin Nutlin-3a | 1 | 0 |
| CCT007093 + Nutlin-3a | CCT007093 Nutlin-3a | 0 | 0 |
| Cisplatin + Nutlin-3a | Cisplatin Nutlin-3a | 2 | 0 |
| CTX-1 + Nutlin-3a | CTX-1 Nutlin-3a | 2 | 0 |
| Doxorubicin + Nutlin-3a | Doxorubicin Nutlin-3a | 4 | 0 |
| Etoposide + Nutlin-3a | Etoposide Nutlin-3a | 2 | 0 |
| GSK2830371 + Nutlin-3a | GSK2830371 Nutlin-3a | 0 | 0 |
| Nutlin-3a | Nutlin-3a | 9 | 0 |
| Nutlin-3a + Paclitaxel | Nutlin-3a Paclitaxel | 0 | 0 |
| Nutlin-3a + RG7112 | Nutlin-3a RG7112 | 0 | 0 |